Skip to main content

Table 1 Characteristics of 310 adults with HIV evaluated for pulmonary tuberculosis, Nigeria (June 2013- June 2015)

From: Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study

Characteristics Total Population
(n = 310)
Treated for TB
(n = 76)
No evidence of TB
(n = 234)
P-value
Age,years, Mean (SD) 38.5 (10.6) 35.7 (9.6) 39.4 (10.7) 0.007
Sex     0.03
 Male, n (%) 115 (37.1) 36 (47.4) 79 (33.8)  
 Female, n (%) 195 (62.9) 40 (52.6) 155 (66.2)  
Body Mass Index 21.9 (3.9) 20.9 (3.8) 22.3 (3.9) 0.02
TB symptoms
 †Cough duration,Weeks, Median (IQR) 3 (2–6) 4 (2–8) 3 (2–5) 0.002
 Fever, n (%) 227 (73.2) 62 (81.6) 165 (70.5) 0.06
 Weight loss, n (%) 250 (80.6) 67 (88.2) 183 (78.2) 0.06
 Night Sweat, n (%) 209 (67.4) 56 (73.7) 153 (65.4) 0.18
 Cough > 2 weeks, n (%) 195 (62.9) 56 (73.7) 139 (59.4) 0.03
Previous TB treatment, n (%) 81 (26.1) 11 (14.5) 70 (29.9) 0.008
On ART, n (%) 273 (88.1) 63 (82.9) 210 (89.1) 0.34
†Latest CD4 Count, cells/mm3, (Median, IQR) 242 (120–425) 224 (99–354) 259 (128–457) 0.11
  1. SD Standard deviation, IQR Interquartile range, TB Tuberculosis, ART Antiretroviral Therapy, †Mann Whitney U test